Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden

Sponsor
Lymphoma Study Association
Study ID
NCT00136552
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to assess in a prospective multicentric study (Phase III) the introduction of a monoclonal antibody directed against B-cells associated with a standard therapy including chemotherapy and alpha-interferon in first line treatment of patients with a large tumor burden follicular lymphoma.

Key Dates

Start date
May 31, 2000
Status verified
Jul 2007
Completion
Dec 31, 2004

Study Design

Enrollment
360 participants
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Primary Outcome Measure

Event free survival

Related Studies